Literature DB >> 7760353

The cellular basis of dilated cardiomyopathy in humans.

C A Beltrami1, N Finato, M Rocco, G A Feruglio, C Puricelli, E Cigola, E H Sonnenblick, G Olivetti, P Anversa.   

Abstract

The present investigation was designed to evaluate whether end-stage cardiac failure in patients affected by dilated cardiomyopathy (DC) was dependent upon extensive myocyte cell death with reduction in muscle mass or was the consequence of collagen accumulation in the myocardium independently from myocyte cell loss. In addition, the mechanisms of ventricular dilation were analysed in order to determine whether the changes in cardiac anatomy were important variables in the development of intractable congestive heart failure. DC is characterized by chamber dilation, myocardial scarring and myocyte hypertrophy in the absence of significant coronary atherosclerosis. However, the relative contribution of each of these factors to the remodeling of the ventricle is currently unknown. Moreover, no information is available concerning the potential etiology of collagen deposition in the myocardium and the changes in number and size of ventricular myocytes with this disease. Morphometric methodologies were applied to the analysis of 10 DC hearts obtained from patients undergoing cardiac transplantation. An identical number of control hearts was collected from individuals who died from causes other than cardiovascular diseases. DC produced a 2.2-fold and 4.2-fold increase in left ventricular weight and chamber volume resulting in a 48% reduction in mass-to-volume ratio. In the right ventricle, tissue weight and chamber size were both nearly doubled. Left ventricular dilation was the result of a 59% lengthening of myocytes and a 20% increase in the transverse circumference due to slippage of myocytes within the wall. Myocardial scarring represented by segmental, replacement and interstitial fibrosis occupied approximately 20% of each ventricle, and was indicative of extensive myocyte cell loss. However, myocyte number was not reduced and average cell volume increased 2-fold in both ventricles. In conclusion, reactive growth processes in myocytes and architectural rearrangement of the muscle compartment of the myocardium appear to be the major determinants of ventricular remodeling and the occurrence of cardiac failure in DC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760353     DOI: 10.1016/s0022-2828(08)80028-4

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  58 in total

1.  Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study.

Authors:  M L Higuchi; S Fukasawa; T De Brito; L C Parzianello; G Bellotti; J A Ramires
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 2.  Regional myocardial mechanics: integrative computational models of flow-function relations.

Authors:  A D McCulloch; R Mazhari
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

3.  Potential role of high molecular weight calmodulin-binding protein in cardiac injury.

Authors:  Anuraag Shrivastav; Rajendra K Sharma
Journal:  Int J Angiol       Date:  2009

4.  Effect of heterogeneities in the cellular microstructure on propagation of the cardiac action potential.

Authors:  Amadou Toure; Candido Cabo
Journal:  Med Biol Eng Comput       Date:  2012-06-23       Impact factor: 2.602

5.  Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.

Authors:  V I Kapelko
Journal:  Exp Clin Cardiol       Date:  2001

6.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

7.  MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway.

Authors:  Jing Zhao; Li Li; Ling Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

8.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Authors:  M A Sussman; S Welch; N Gude; P R Khoury; S R Daniels; D Kirkpatrick; R A Walsh; R L Price; H W Lim; J D Molkentin
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

9.  Nonrigid active shape model-based registration framework for motion correction of cardiac T1 mapping.

Authors:  Hossam El-Rewaidy; Maryam Nezafat; Jihye Jang; Shiro Nakamori; Ahmed S Fahmy; Reza Nezafat
Journal:  Magn Reson Med       Date:  2018-01-03       Impact factor: 4.668

10.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Authors:  Katherine C Wu; Robert G Weiss; David R Thiemann; Kakuya Kitagawa; André Schmidt; Darshan Dalal; Shenghan Lai; David A Bluemke; Gary Gerstenblith; Eduardo Marbán; Gordon F Tomaselli; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-06-24       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.